PACT Pharma clinical stage biotechnology company developing personalized adoptive T cell therapies for the eradication of solid tumors.

Register for Details

For more details on financing and valuation for Pact Pharma, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Pact Pharma

Forge green plus iconForge green minus icon

What is Pact Pharma's funding to date?

Pact Pharma has raised $354.6MM to date.
Forge green plus iconForge green minus icon

When was Pact Pharma founded?

Pact Pharma was founded in 2016.

Pact Pharma Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
9/30/2022 Series D $104.1MM raised $XXX.XX $XXX.XX
6/15/2020 Series C-1 $50MM raised $XXX.XX $XXX.XX
1/10/2020 Series C $75MM raised $XXX.XX $XXX.XX
5/25/2018 Series B $95.5MM raised $XXX.XX $XXX.XX
12/20/2016 Series A $30MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Nov 15, 2023


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.